National Health Investors (NYSE:NHI) Issues FY 2024 Earnings Guidance

by · The Cerbat Gem

National Health Investors (NYSE:NHI – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.430-4.440 for the period, compared to the consensus estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Price Performance

NYSE NHI traded up $0.81 during trading on Tuesday, reaching $76.73. 340,585 shares of the company traded hands, compared to its average volume of 190,436. National Health Investors has a 1-year low of $49.25 and a 1-year high of $86.13. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. The stock’s 50 day moving average price is $80.53 and its two-hundred day moving average price is $73.03. The company has a market cap of $3.33 billion, a price-to-earnings ratio of 26.00, a P/E/G ratio of 5.09 and a beta of 1.05.

National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). The company had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The firm’s revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.06 earnings per share. As a group, analysts anticipate that National Health Investors will post 4.48 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on NHI shares. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Truist Financial increased their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $73.29.

Get Our Latest Analysis on National Health Investors

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles